Publicaciones en las que colabora con Pedro Ramos Cabrer (13)

2024

  1. Multimodal imaging of the role of hyperglycemia following experimental subarachnoid hemorrhage

    Journal of Cerebral Blood Flow and Metabolism, Vol. 44, Núm. 5, pp. 726-741

  2. Urease-powered nanobots for radionuclide bladder cancer therapy

    Nature Nanotechnology, Vol. 19, Núm. 4, pp. 554-564

2023

  1. Therapeutic effect of α7 nicotinic receptor activation after ischemic stroke in rats

    Journal of Cerebral Blood Flow and Metabolism, Vol. 43, Núm. 8, pp. 1301-1316

2022

  1. Aberrant upregulation of the glycolytic enzyme PFKFB3 in CLN7 neuronal ceroid lipofuscinosis

    Nature Communications, Vol. 13, Núm. 1

  2. Longitudinal evaluation of neuroinflammation and oxidative stress in a mouse model of Alzheimer disease using positron emission tomography

    Alzheimer's Research and Therapy, Vol. 14, Núm. 1

2021

  1. Erratum: PLGA protein nanocarriers with tailor-made fluorescence/MRI/PET imaging modalities (Nanoscale (2020) 12(4988–5002) DOI: 10.1039/c9nr10620k)

    Nanoscale

  2. Longitudinal evaluation of a novel BChE PET tracer as an early in vivo biomarker in the brain of a mouse model for Alzheimer disease

    Theranostics, Vol. 11, Núm. 13, pp. 6542-6559

  3. Swarming behavior and in vivo monitoring of enzymatic nanomotors within the bladder

    Science Robotics, Vol. 6, Núm. 52

2020

  1. In vivo multimodal imaging of adenosine A1 receptors in neuroinflammation after experimental stroke

    Theranostics, Vol. 11, Núm. 1, pp. 410-425

  2. PLGA protein nanocarriers with tailor-made fluorescence/MRI/PET imaging modalities

    Nanoscale, Vol. 12, Núm. 8, pp. 4988-5002

2019

  1. Immuno-PET Imaging and Pharmacokinetics of an Anti-CEA scFv-based Trimerbody and Its Monomeric Counterpart in Human Gastric Carcinoma-Bearing Mice

    Molecular Pharmaceutics, Vol. 16, Núm. 3, pp. 1025-1035

2018

  1. In vivo imaging of Α7 nicotinic receptors as a novel method to monitor neuroinflammation after cerebral ischemia

    GLIA, Vol. 66, Núm. 8, pp. 1611-1624

  2. PEG-copolymer-coated iron oxide nanoparticles that avoid the reticuloendothelial system and act as kidney MRI contrast agents

    Nanoscale, Vol. 10, Núm. 29, pp. 14153-14164